Literature DB >> 12427546

Characterization of a human sphingosine-1-phosphate receptor gene (S1P5) and its differential expression in LGL leukemia.

Ravi Kothapalli1, Irina Kusmartseva, Thomas P Loughran.   

Abstract

Large granular lymphocyte (LGL) leukemia is a lymphoproliferative disorder often associated with autoimmune disease. A central feature of this disease is dysregulation of apoptosis. In order to identify differentially expressed genes in LGL leukemia, microarray analysis was performed. We found many differentially expressed genes including several expression sequence tags (ESTs). As a systematic study, we selected one up-regulated EST (GenBank Accession number N47089) and further investigated. An LGL leukemia library was screened using this EST as a probe and a full-length sequence for a novel gene was identified. The deduced amino acid sequence revealed that the novel gene encodes a G-protein-coupled receptor gene that exhibits 86% identity with rat sphingosine-1-phosphate receptor (edg-8/nrg-1). This gene is present in brain, spleen, and peripheral blood mononuclear cells (PBMC) and is overexpressed in leukemic LGL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427546     DOI: 10.1016/s0167-4781(02)00529-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

Review 1.  Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond.

Authors:  Kenneth C Loh; Dianna Baldwin; Julie D Saba
Journal:  Anticancer Agents Med Chem       Date:  2011-11       Impact factor: 2.505

Review 2.  Targeting sphingosine-1-phosphate in hematologic malignancies.

Authors:  Christina E Stevenson; Kazuaki Takabe; Masayuki Nagahashi; Sheldon Milstien; Sarah Spiegel
Journal:  Anticancer Agents Med Chem       Date:  2011-11       Impact factor: 2.505

Review 3.  Targeting sphingosine-1-phosphate receptors in cancer.

Authors:  Rebecca J Watters; Hong-Gang Wang; Shen-Shu Sung; Thomas P Loughran; Xin Liu
Journal:  Anticancer Agents Med Chem       Date:  2011-11       Impact factor: 2.505

Review 4.  T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias.

Authors:  Rebecca J Watters; Xin Liu; Thomas P Loughran
Journal:  Leuk Lymphoma       Date:  2011-07-13

Review 5.  Sphingosine 1-phosphate and cancer.

Authors:  Nigel J Pyne; Susan Pyne
Journal:  Nat Rev Cancer       Date:  2010-06-17       Impact factor: 60.716

Review 6.  Never say die: survival signaling in large granular lymphocyte leukemia.

Authors:  Mithun Vinod Shah; Ranran Zhang; Thomas P Loughran
Journal:  Clin Lymphoma Myeloma       Date:  2009

7.  Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.

Authors:  Francis R LeBlanc; Xin Liu; Jeremy Hengst; Todd Fox; Valerie Calvert; Emanuel F Petricoin; Jong Yun; David J Feith; Thomas P Loughran
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

8.  Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes.

Authors:  Mithun Vinod Shah; Ranran Zhang; Rosalyn Irby; Ravi Kothapalli; Xin Liu; Ty Arrington; Bryan Frank; Norman H Lee; Thomas P Loughran
Journal:  Blood       Date:  2008-05-13       Impact factor: 22.113

Review 9.  Large granular lymphocyte leukemia: from dysregulated pathways to therapeutic targets.

Authors:  Francis Leblanc; Dan Zhang; Xin Liu; Thomas P Loughran
Journal:  Future Oncol       Date:  2012-07       Impact factor: 3.404

Review 10.  Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.

Authors:  M T M van Jaarsveld; J M Houthuijzen; E E Voest
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.